Search research articles
Contact Us
Filters
Showing results (41-50 of 2,347) with videos related to
Page
of 235
Sort By:
Journal of Magnetic Resonance Imaging : JMRI
|
August 25, 2022
Editorial for "Simultaneous Acquisition of Diffusion Tensor and Dynamic Diffusion MRI"
Ming-Long Wu, Hsiao-Wen Chung
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 25, 2021
Combination Chemotherapy Alone Should Be Used in the Treatment of Patients With Stage IV EGFR-Mutant NSCLC Whose Disease Has Progressed on All Available Tyrosine Kinase Inhibitors
Jia-Tao Zhang, Yi-Long Wu
Polymers
|
July 30, 2020
Gene Cloning, Characterization, and Molecular Simulations of a Novel Recombinant Chitinase from Chitinibacter Tainanensis CT01 Appropriate for Chitin Enzymatic Hydrolysis
Yeng-Tseng Wang, Po-Long Wu
Discover Oncology
|
December 22, 2025
Potential value of m6A-related lncRNAs in diagnosis and therapy of pancreatic cancer
Long Wu, Yunting Zhang, Dandan Wu
Perfusion
|
May 4, 2024
Is axillary artery cannulation necessary in type II hybrid aortic arch repair for acute type A aortic dissection?
Zhonglai Zhu, Long Wu, Yanhong Yuan
Oncotargets and Therapy
|
May 23, 2015
Personalized treatment strategies for non-small-cell lung cancer in Chinese patients: the role of crizotinib
Fei-Yu Niu, Yi-Long Wu
JAMA Oncology
|
June 1, 2018
Immune-Related Adverse Events-A Novel Prediction of Nivolumab Efficacy?
Yanlei Cheng, Yaogui Wu, Long Wu
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 26, 2021
Unmet Clinical Demand for Patients With Unresectable Stage III NSCLC Having Actionable Genetic Alterations
Si-Yang Liu, Yi-Long Wu
Journal of Medical Systems
|
February 28, 2012
A balanced scorecard approach in assessing IT value in healthcare sector: an empirical examination
Ing-Long Wu, Yi-Zu Kuo
Therapeutic Advances in Respiratory Disease
|
March 2, 2016
Afatinib in the first-line treatment of epidermal-growth-factor-receptor mutation-positive non-small cell lung cancer: a review of the clinical evidence
E-E Ke, Yi-Long Wu
Page
of 235
Search research articles
Search
Showing results (41-50 of 2,347) with videos related to
Sort By:
Page
of 235
Journal of Magnetic Resonance Imaging : JMRI
|
August 25, 2022
Editorial for "Simultaneous Acquisition of Diffusion Tensor and Dynamic Diffusion MRI"
Ming-Long Wu, Hsiao-Wen Chung
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 25, 2021
Combination Chemotherapy Alone Should Be Used in the Treatment of Patients With Stage IV EGFR-Mutant NSCLC Whose Disease Has Progressed on All Available Tyrosine Kinase Inhibitors
Jia-Tao Zhang, Yi-Long Wu
Polymers
|
July 30, 2020
Gene Cloning, Characterization, and Molecular Simulations of a Novel Recombinant Chitinase from Chitinibacter Tainanensis CT01 Appropriate for Chitin Enzymatic Hydrolysis
Yeng-Tseng Wang, Po-Long Wu
Discover Oncology
|
December 22, 2025
Potential value of m6A-related lncRNAs in diagnosis and therapy of pancreatic cancer
Long Wu, Yunting Zhang, Dandan Wu
Perfusion
|
May 4, 2024
Is axillary artery cannulation necessary in type II hybrid aortic arch repair for acute type A aortic dissection?
Zhonglai Zhu, Long Wu, Yanhong Yuan
Oncotargets and Therapy
|
May 23, 2015
Personalized treatment strategies for non-small-cell lung cancer in Chinese patients: the role of crizotinib
Fei-Yu Niu, Yi-Long Wu
JAMA Oncology
|
June 1, 2018
Immune-Related Adverse Events-A Novel Prediction of Nivolumab Efficacy?
Yanlei Cheng, Yaogui Wu, Long Wu
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 26, 2021
Unmet Clinical Demand for Patients With Unresectable Stage III NSCLC Having Actionable Genetic Alterations
Si-Yang Liu, Yi-Long Wu
Journal of Medical Systems
|
February 28, 2012
A balanced scorecard approach in assessing IT value in healthcare sector: an empirical examination
Ing-Long Wu, Yi-Zu Kuo
Therapeutic Advances in Respiratory Disease
|
March 2, 2016
Afatinib in the first-line treatment of epidermal-growth-factor-receptor mutation-positive non-small cell lung cancer: a review of the clinical evidence
E-E Ke, Yi-Long Wu
Page
of 235